List of Excipients in API brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide
Detailed excipient profiles for brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide
Excipient focus: ALCOHOL
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants containing ALCOHOL
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants not containing ALCOHOL
Excipient focus: ANHYDROUS CITRIC ACID
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants containing ANHYDROUS CITRIC ACID
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants containing FD&C RED NO. 40
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide | 51672-4165 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants containing GLYCERIN
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants containing METHYLPARABEN
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants containing PROPYLENE GLYCOL
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC | brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide | 0121-0933 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants containing SODIUM BENZOATE
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants containing SODIUM CITRATE
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants not containing SODIUM CITRATE
Excipient focus: SUCRALOSE
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants containing SUCRALOSE
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants not containing SUCRALOSE
Excipient focus: SUCROSE
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants containing SUCROSE
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants not containing SUCROSE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants containing TRISODIUM CITRATE DIHYDRATE
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants containing WATER
brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide | 62135-302 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
